| DC Field | Value | Language |
|---|
| dc.contributor.author | Voronkov, D. N. | - |
| dc.contributor.author | Stavrovskaya, A. V. | - |
| dc.contributor.author | Pavlova, A. K. | - |
| dc.contributor.author | Potapov, I. A. | - |
| dc.contributor.author | Olshansky, A. S. | - |
| dc.date.accessioned | 2026-03-19T07:05:33Z | - |
| dc.date.available | 2026-03-19T07:05:33Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Semaglutide reduces hypothalamic glial cell damage in a streptozocin-induced model of Alzheimer's disease / D.N. Voronkov, A.V. Stavrovskaya, A.K. Pavlova [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №4.-P. 66-77. - Doi: 10.18413/rrpharmacology.11.804. - Refer.: p. 75-77. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/66372 | - |
| dc.description.abstract | Reactive changes in glial cells, as well as their dysfunction, particularly cerebrospinal fluid dynamics disturbances, are associated with multiple neurodegenerative diseases and Alzheimer’s disease (AD). Intraventricular administration of streptozotocin (STZ) is considered a model of sporadic AD, though data on hypothalamic glial cell changes, ependymal glia, and tanycytes in this model remain limited | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | astrocytes | ru |
| dc.subject | ependymal cells | ru |
| dc.subject | Alzheimer's disease | ru |
| dc.subject | streptozotocin | ru |
| dc.subject | semaglutide | ru |
| dc.title | Semaglutide reduces hypothalamic glial cell damage in a streptozocin-induced model of Alzheimer's disease | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 4
|
